No Evidence of PPI Use Is Linked to Dementia or Alzheimer Disease
April 3rd 2018Despite recent concerns about proton pump inhibitor (PPI) safety, the results of a recently published study found no evidence that PPI use contributes to a higher risk of dementia or Alzheimer disease in older adults.
Read More
FDA Expands Indication of ALL Treatment for Patients with Increased Relapse Risk
March 30th 2018Officials with the FDA have expanded the approval of Amgen's blinatumomab (Blincyto) to include the treatment of adults and children with B-cell precursor acute lymphoblastic leukemia who are in remission but still have minimal residual disease.
Read More